Amendment to Rule 89 of the Drugs Rules, 1945 for obtaining licence under Form 29 for additional manufacturing licence categories

Posted by: Hitesh Gupta August 13, 2026

Government Clarifies Status of AI-Based Breast Cancer Screening under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD)

Posted by: Prabhas Chakraborty August 10, 2026

NPPA Issues Clarifications on Filing of Form-IA for New Drugs under the Drugs (Prices Control) Amendment Order, 2026

Posted by: Prabhas Chakraborty August 10, 2026

Debarment of Applicants Submitting Misleading, Fake, or Fabricated Documents under the Drugs Rules, 1945

Posted by: Hitesh Gupta August 10, 2026

Extension in date of implementation of IS 16102 (Part 1):2026

Posted by: Hitesh Gupta August 10, 2026

7
Comments Off on Extension in date of implementation of IS 16102 (Part 1):2026
10th August, 2026

Extension in date of implementation of Revised Standards for LED Luminaires

Posted by: Hitesh Gupta August 10, 2026

7
Comments Off on Extension in date of implementation of Revised Standards for LED Luminaires
10th August, 2026

Extension date for implementation of IS 18112 ‘Digital Television Receiver for satellite Broadcast Transmission Specification’

Posted by: Hitesh Gupta August 10, 2026

CDSCO Issues Revised Guidance on Common Submission Format for Import and Registration of Bulk Drugs and Finished Formulations in India

Posted by: Hitesh Gupta August 10, 2026

What's New 2?

Regulation/Guidelines

AI/ML-Based Medical Devices — Emerging Regulatory Questions

Traditional Medical Device regulation assumes a fixed product: what’s approved is what ships, indefinitely, until a formal change is filed and reviewed. Adaptive AI and machine learning algorithms break that...

24th August, 2026

Regulation/Guidelines

Post-Market Surveillance for Cosmetics in India: What CDSCO Expects After Launch

Getting a Cosmetic product registered and onto shelves in India is only half the job. Once a product is in the market, the Cosmetics Rules, 2020 place ongoing duties on...

19th August, 2026

Regulation/Guidelines

Software as a Medical Device (SaMD) – India’s Regulatory Stance

Although software intended for Medical purposes has been regulated in India since the implementation of MDR, 2017 Rules. CDSCO's Guidance Document on Medical Device Software (Doc No. CDSCO/MD/GD/MDSW/01/2026), issued on...

18th August, 2026

Regulation/Guidelines

The Future of Biological Regulation in India: Biosimilars, CAR-T, AI & Advanced Therapies

India's Biological Regulatory landscape is at an inflection point. The country that pioneered affordable Biosimilar access, built one of the world's largest vaccine manufacturing ecosystems, and established the framework for...

14th August, 2026

Amendment to Rule 89 of the Drugs Rules, 1945 for obtaining licence under Form 29 for additional manufacturing licence categories

Government Clarifies Status of AI-Based Breast Cancer Screening under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD)

NPPA Issues Clarifications on Filing of Form-IA for New Drugs under the Drugs (Prices Control) Amendment Order, 2026

Debarment of Applicants Submitting Misleading, Fake, or Fabricated Documents under the Drugs Rules, 1945

Extension in date of implementation of IS 16102 (Part 1):2026

Extension in date of implementation of Revised Standards for LED Luminaires

Extension date for implementation of IS 18112 ‘Digital Television Receiver for satellite Broadcast Transmission Specification’

CDSCO Issues Revised Guidance on Common Submission Format for Import and Registration of Bulk Drugs and Finished Formulations in India

For Importers To India

Drug

Biologicals

Food Supplements

Medical Device

IVD

Food

Cosmetic

Other

For Manufacturer in India

Drug

Biologicals

Food Supplements

Food

Medical Device

IVD

Cosmetic

Other